Literature DB >> 10683009

School-based hepatitis B vaccination programme and adolescent multiple sclerosis.

A D Sadovnick, D W Scheifele.   

Abstract

We investigated multiple sclerosis in adolescents in British Columbia before and after a hepatitis B vaccination programme was begun. There was no evidence of a link between hepatitis B vaccination and multiple sclerosis or other demyelinating disease.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10683009     DOI： 10.1016/S0140-6736(99)02991-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  13 in total

Review 1.  Demyelinating disease and hepatitis B vaccination: is there a link?

Authors:  T Jefferson; H Heijbel
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 2.  [Multiple sclerosis and hepatitis B vaccination : What does the verdict of the European Court of Justice on liability after vaccination mean?]

Authors:  M Löbermann; B Handorn; A Winkelmann; E C Reisinger; H P Hartung; U K Zettl
Journal:  Nervenarzt       Date:  2018-10       Impact factor: 1.214

Review 3.  [Vaccination and multiple sclerosis].

Authors:  M Löbermann; A Winkelmann; E C Reisinger; U K Zettl
Journal:  Nervenarzt       Date:  2010-02       Impact factor: 1.214

Review 4.  Current Immunological and Clinical Perspective on Vaccinations in Multiple Sclerosis Patients: Are They Safe after All?

Authors:  Shani Witman Tsur; Eli Adrian Zaher; Meydan Tsur; Karolina Kania; Alicja Kalinowska-Łyszczarz
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

Review 5.  Specific aspects of modern life for people with multiple sclerosis: considerations for the practitioner.

Authors:  Celia Oreja-Guevara; Heinz Wiendl; Bernd C Kieseier; Laura Airas
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

Review 6.  Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B.

Authors:  Gillian M Keating; Stuart Noble
Journal:  Drugs       Date:  2003       Impact factor: 9.546

7.  Negative perceptions of hepatitis B vaccination among attendees of an urban free testing center for sexually transmitted infections in France.

Authors:  Lauranne Moyroud; Sarah Hustache; Laurence Goirand; Marianne Hauzanneau; Olivier Epaulard
Journal:  Hum Vaccin Immunother       Date:  2016-12-12       Impact factor: 3.452

Review 8.  Central nervous system demyelinating diseases and recombinant hepatitis B vaccination: a critical systematic review of scientific production.

Authors:  V Martínez-Sernández; A Figueiras
Journal:  J Neurol       Date:  2012-10-20       Impact factor: 4.849

Review 9.  Vaccines and multiple sclerosis: a systematic review.

Authors:  Mia Topsøe Mailand; Jette Lautrup Frederiksen
Journal:  J Neurol       Date:  2016-09-07       Impact factor: 6.682

10.  Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination.

Authors:  Dominique Le Houézec
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.